Detection and quantification of mutations in the plasma of patients with colorectal tumors
Open accessThe DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
The early detection of cancers through analysis of circulating DNA could have a substantial impact on morbidity and mortality. To achieve this goal, it is essential to determine the number of mutant molecules present in the circulation of cancer patients and to develop methods that are sufficiently sensitive to detect these mutations. Using a modified version of a recently developed assay for this purpose, we found that patients with advanced colorectal cancers consistently contained mutant adenomatous polyposis coli ( APC ) DNA molecules in their plasma. The median number of APC DNA fragments in such patients was 47,800 per ml of plasma, of which 8% were mutant. Mutant APC molecules were also detected in >60% of patients with early, presumably curable colorectal cancers, at levels ranging from 0.01% to 1.7% of the total APC molecules. These results have implications for the mechanisms through which tumor DNA is released into the circulation and for diagnostic tests based on this phenomenon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is a crucial consideration when considering cfDNA as a template as its concentration can range considerably; from 2 to 30 ng/ml plasma in healthy individuals to 180–600 ng/ml plasma both during pregnancy and in cancer patients (13,16,18,22–24).”
From Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation (2012) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Self-citationCancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Self-citationJahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,549
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
(1977) · PubMed · Cited by 1,801
Rapid Clearance of Fetal DNA from Maternal Plasma
Lo, Y. M. D., Zhang, J., Leung, T. N., Lau, T. K., Chang, A. M. Z., & Hjelm, N. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302205 · Cited by 1,157
Systemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,043
Systemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples
Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., et al. (1991) · Science · doi:10.1126/science.2024123 · Cited by 875
Self-citationDressman, D., Yan, H., Traverso, G., Kinzler, K. W., & Vogelstein, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133470100 · Cited by 844
Self-citation
Research works printed but not linked: 4
- 10.1002/(SICI)1096-9896(200001)190:1<6::AID-PATH486>3.0.CO;2-M · doi:10.1002/(sici)1096-9896(200001)190:1<6::aid-path486>3.0.co;2-m
- Leon, S. A., Shapiro, B., Sklaroff, D. M. & Yaros, M. J. (1977) Cancer Res. 37, 646-650.837366
- Sozzi, G., Conte, D., Mariani, L., Lo Vullo, S., Roz, L., Lombardo, C., Pierotti, M. A. & Tavecchio, L. (2001) Cancer Res. 61, 4675-4678.11406535
- Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D. & Knippers, R. (2001) Cancer Res. 61, 1659-1665.11245480
Cited by
Items 601–700 of 1,000
Detection and Quantification of Mutations in the Plasma of Patients With Colorectal Tumors
Kochman, M. L. (2006) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(08)70319-2 · Cited by 23
Evidence for cell-free nucleic acids as continuously arising endogenous DNA mutagens
Basak, R., Nair, N. K., & Mittra, I. (2016) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2016.10.002 · Cited by 24
The In Vitro Stability of Circulating Tumour DNA
Diaz, E. H., Yachnin, J., Grönberg, H., & Lindberg, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168153 · Cited by 23
Future perspectives of circulating tumor DNA in colorectal cancer
Nadal, C., Winder, T. L., Gerger, A., & Tougeron, D. (2017) · Tumor Biology · doi:10.1177/1010428317705749 · Cited by 27
Toward liquid biopsies in cancer treatment: application of circulating tumor DNA
Ahlborn, L. B., & Østrup, O. (2019) · Apmis · doi:10.1111/apm.12912 · Cited by 28
Meng, P., Wei, J., Geng, Y., Chen, S., Terpstra, M. M., Huang, Q., Zhang, Q., Su, Z., Yu, W., Su, M., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-6025-2 · Cited by 24
Chasing ctDNA in Patients With Sarcoma
Coombs, C. C., Dickherber, T., & Crompton, B. D. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_280749 · Cited by 25
Hudečková, M., Koucký, V., Rottenberg, J., & Gál, B. (2021) · Biomedicines · doi:10.3390/biomedicines9111548 · Cited by 26
Cell-free DNA as a biomarker in cancer
Eibl, R. H., & Schneemann, M. (2022) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2022.20 · Cited by 23
Extracellular vesicle DNA from human melanoma tissues contains cancer-specific mutations
Crescitelli, R., Filges, S., Karimi, N., Urzì, O., Alonso-Agudo, T., Ståhlberg, A., Lötvall, J. O., Lässer, C., & Bagge, R. O. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1028854 · Cited by 23
Stosic, K., Senar, O. A., Tarfouss, J., Bouchart, C., Navez, J., Laethem, J. V., & Arsenijevic, T. (2023) · Cells · doi:10.3390/cells13010003 · Cited by 24
Liquid Biopsy by Next-Generation Sequencing: a Multimodality Test for Management of Cancer
Achi, H. E., Khoury, J. D., & Loghavi, S. (2019) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-019-00532-w · Cited by 23
Wei, J., Liu, X., Li, T., Xing, P., Zhang, C., & Yang, J. (2020) · Journal of Cancer · doi:10.7150/jca.42816 · Cited by 21
Ray, S. K., & Mukherjee, S. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666201211102710 · Cited by 24
Haupts, A., Vogel, A., Foersch, S., Hartmann, M., Maderer, A., Wachter, N., Huber, T., Kneist, W., Roth, W., Lang, H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-95006-6 · Cited by 27
Spinney, L. (2006) · Nature · doi:10.1038/442736a · Cited by 22
Personalized treatment for advanced colorectal cancer: KRAS and beyond
Karapetis, C. S., & Patel, G. S. (2013) · Cancer Management and Research · doi:10.2147/cmar.s35025 · Cited by 24
Shin, S., Chun, S., Kim, T., Kim, Y. J., Choi, H.-J., Jang, S. J., & Kim, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176340 · Cited by 21
An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA
Vitale, S. R., Sieuwerts, A. M., Beije, N., Kraan, J., Angus, L., Mostert, B., Reijm, E. A., Van, N. M., van Marion, R., Dirix, L. Y., et al. (2018) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2018.08.010 · Cited by 20
Opportunities of circulating tumor DNA in lung cancer
Wu, T., Hsiue, E. H.-C., & Yang, J. C. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.07.002 · Cited by 21
Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer
Pešta, M., Shetti, D., Kulda, V., Knížková, T., Houfková, K., Bagheri, M. S., Svatoň, M., & Polívka, J. (2022) · Diagnostics · doi:10.3390/diagnostics12081799 · Cited by 23
Sequence-Based Platforms for Discovering Biomarkers in Liquid Biopsy of Non-Small-Cell Lung Cancer
Brockley, L. J., Souza, V. G. P., Forder, A., Pewarchuk, M. E., Erkan, M., Telkar, N., Benard, K., Trejo, J., Stewart, M. D., Stewart, G. L., et al. (2023) · Cancers · doi:10.3390/cancers15082275 · Cited by 27
Rand, K. N., Young, G. P., Ho, T., & Molloy, P. L. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks831 · Cited by 21
Incidence and prognostic value of multiple gene promoter methylations in gliomas
Zhang, L., Wang, M., Wang, W., & Mo, J. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1301-5 · Cited by 21
Mokarram, P., Rismanchi, M., Naeeni, M. A., Samiee, S. M., Paryan, M., Alipour, A., Honardar, Z., Kavousipour, S., Naghibalhossaini, F., Mostafavi‐Pour, Z., et al. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3138-1 · Cited by 20
The Pursuit of Noninvasive Diagnosis of Lung Cancer
Atwater, T., Cook, C., & Massion, P. P. (2016) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0036-1592314 · Cited by 23
Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine?
Pi, C., Zhang, M., Peng, X., Zhang, Y., Xu, C., & Zhou, Q. H. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1395701 · Cited by 22
Circulating Tumour DNA in Muscle-Invasive Bladder Cancer
Tan, M. L. H., Attard, G., & Huddart, R. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092568 · Cited by 23
Wood-Bouwens, C. M., Haslem, D. S., Moulton, B., Almeda, A. F., Lee, H., Heestand, G. M., Nadauld, L. D., & Ji, H. P. (2019) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2019.10.008 · Cited by 21
Liquid biopsy in chronic liver disease
Barrera-Saldaña, H. A., Fernández-Garza, L. E., & Barrera‐Barrera, S. A. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.03.008 · Cited by 24
MALDI-TOF Mass Spectrometry for Analyzing Cell-Free Fetal DNA in Maternal Plasma
Ding, C. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-066-9_20 · Cited by 21
Gryfe, R. (2006) · Surgical Clinics of North America · doi:10.1016/j.suc.2006.05.007 · Cited by 29
Clark, K. D., Zhu, C., & Anderson, J. L. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b00350 · Cited by 20
Recent technologies enhancing the clinical utility of circulating tumor DNA
Manoharan, A., Ravikumar, S., & Bhat, V. B. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.08.010 · Cited by 21
Circulating tumor DNA detection and its application status in gastric cancer: a narrative review
Chen, W., Yan, H., Li, X., Ge, K., & Wu, J. (2021) · Translational Cancer Research · doi:10.21037/tcr-20-2856 · Cited by 23
Zhao, H., Niu, Z., Chen, K., Chen, L., Wang, Z., Lan, M., Shi, J., & Huang, W. (2021) · Microchemical Journal · doi:10.1016/j.microc.2021.106783 · Cited by 19
Fiala, O., Baxa, J., Svatoň, M., Benešová, L., Ptáčková, R., Hálková, T., Minárik, M., Hošek, P., Buresova, M., Fínek, J., et al. (2022) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20319 · Cited by 23
Carvalho, J. V. M., Dutoit, V., Corrò, C., & Koessler, T. (2023) · Cells · doi:10.3390/cells12030413 · Cited by 24
Circulating Tumor Cells: What Is in It for the Patient? A Vision towards the Future
van de Stolpe, A., & den Toonder, J. M. J. (2014) · Cancers · doi:10.3390/cancers6021195 · Cited by 21
Liquid Biopsy in Solid Malignancy
Scarlotta, M., Şimşek, C., & Kim, A. K. (2019) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2018.0237 · Cited by 26
Haselmann, V., Hedtke, M., & Neumaier, M. (2022) · Diagnostics · doi:10.3390/diagnostics12030748 · Cited by 22
Garcia, J., Wozny, A., Geiguer, F., Delherme, A., Barthélémy, D., Merle, P., Tissot, C., Jones, F. S., Johnson, C., Xing, X., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2244 · Cited by 23
He, D., Cui, B., Lv, H., Lu, S., Zhu, Y., Chen, Q., Lin, D., & Zhang, H. (2024) · Biomolecules · doi:10.3390/biom14070847 · Cited by 24
Wang, L., Hu, X., Guo, Q., Huang, X., Lin, C., Chen, X., Li, M., Yao, Q., Zhou, Q., Wang, J., et al. (2019) · Small Methods · doi:10.1002/smtd.201900357 · Cited by 23
Self-citationHsiehchen, D., Espinoza, M., Gerber, D. E., & Beg, M. S. (2021) · Cancer Biology & Therapy · doi:10.1080/15384047.2021.1963166 · Cited by 21
Circulating HPV DNA in HPV-associated cancers
Lin, G., & Li, J. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117269 · Cited by 22
Blow, N. S. (2007) · Nature Methods · doi:10.1038/nmeth1007-869 · Cited by 19
Selected technologies for measuring acquired genetic damage in humans
Shuga, J., Zeng, Y., Novak, R., Mathies, R. A., Hainaut, P. L., & Smith, M. T. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20630 · Cited by 21
Pasternack, H., Fassunke, J., Plum, P. S., Chon, S., Hescheler, D. A., Gassa, A., Merkelbach‐Bruse, S., Bruns, C. J., Perner, S., Hallek, M. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33027-4 · Cited by 19
Emaus, M. N., Zhu, C., & Anderson, J. L. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.10.057 · Cited by 19
Qi, Z., Ma, Y., Deng, L., Wu, H., Zhou, G., Kajiyama, T., & Kambara, H. (2011) · The Analyst · doi:10.1039/c0an00976h · Cited by 19
Early detection of prostate cancer with emphasis on genetic markers
Aly, M., Wiklund, F. E., & Grönberg, H. (2011) · Acta Oncologica · doi:10.3109/0284186x.2010.529824 · Cited by 23
Munteanu, V. C., Munteanu, R. A., Gulei, D., Mărginean, R., Schițcu, V. H., Onaciu, A., Toma, V., STIUFIUC, G., Coman, I., & Stiufiuc, R. I. (2022) · Cancers · doi:10.3390/cancers14133227 · Cited by 20
Fan, W., Dong, Y., Ren, W., & Liu, C. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117035 · Cited by 18
Spindler, K. G., & Jakobsen, A. K. M. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359231171580 · Cited by 21
Re, M. D., Vasile, E., Falcone, A., Danesi, R., & Petrini, I. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.908120 · Cited by 22
PIK3CA mutation detection in metastatic biliary cancer using cell-free DNA
Kim, S. T., Lira, M., Deng, S., Lee, S., Park, Y. S., Lim, H. Y., Kang, W. K., Mao, M., Heo, J. S., Kwon, W., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5432 · Cited by 20
Kim, J., Park, D., Son, D., Nam, S. J., Kim, S. W., Jung, H. H., Kim, Y. J., Park, G., Park, W., Lee, J. E., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21198 · Cited by 19
Role of circulating tumor DNA in the management of patients with colorectal cancer
Moati, É., Taly, V., Didelot, A., Perkins, G., Blons, H., Taïeb, J., Laurent‐Puig, P., & Zaanan, A. (2018) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2018.03.002 · Cited by 21
Pan, M., Chen, P., Lu, J., Liu, Z., Jia, E., & Ge, Q. (2020) · Prenatal Diagnosis · doi:10.1002/pd.5680 · Cited by 19
Liquid Biopsies for Assessing Metastatic Melanoma Progression
Huynh, K. T., & Hoon, D. S. �. (2016) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2016016075 · Cited by 19
Using gold nanoparticles to detect single-nucleotide polymorphisms: toward liquid biopsy
Sanromán-Iglesias, M., & Grzelczak, M. (2020) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.11.20 · Cited by 20
Liu, Z.-B., Ezzeddine, N., Eterovic, A. K., Ensor, J., Huang, H. J., Albanell, J., Choi, D. S., Lluch, A. M., Liu, Y., Rojo, F., et al. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05374-x · Cited by 20
The prognostic value of longitudinal circulating tumor DNA profiling during osimertinib treatment
Ma, S., Shi, M., Chen, X., Wang, Y., Yang, Z., Lizaso, A., Li, M., Li, H., Zhang, L., Mao, X., et al. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-371 · Cited by 19
Self-citationAbouali, H., Hosseini, S. A., Purcell, E., Nagrath, S., & Poudineh, M. (2022) · Cancers · doi:10.3390/cancers14020288 · Cited by 16
Pisareva, E., Roch, B., Sánchez, C., Pastor, B., Mirandola, A., Diab‐Assaf, M., Mazard, T., Prévostel, C., Dache, Z. A. A., & Thierry, A. R. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1104732 · Cited by 20
The clinical role of circulating free tumor DNA in gastrointestinal malignancy
Howell, J. A., Khan, S. A., Knapp, S., Thursz, M. R., & Sharma, R. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.006 · Cited by 18
Circulating tumor DNA (ctDNA) in the era of personalized cancer therapy
Khatami, F., & Tavangar, S. M. (2018) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0334-x · Cited by 20
Epigenetics of Circulating Tumor Cells in Breast Cancer
Bao‐Caamano, A., Rodríguez‐Casanova, A., & Díaz‐Lagares, Á. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35805-1_8 · Cited by 19
Zhou, S., Huang, R., & Cao, Y. (2020) · Medicine · doi:10.1097/md.0000000000021965 · Cited by 19
Siggillino, A., Ulivi, P., Pasini, L., Reda, M. S., Chiadini, E., Tofanetti, F. R., Baglivo, S., Metro, G., Crinò, L., Delmonte, A., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10121062 · Cited by 19
Liu, L., Chen, X., & Wong, K. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab236 · Cited by 19
The promise of methylation on beads for cancer detection and treatment
Guzzetta, A. A., Pisanic, T. R., Sharma, P., Yi, J. M., Stark, A., Wang, T., & Ahuja, N. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.943665 · Cited by 17
Boulanger, J., Mureşan, L., & Tiemann‐Boege, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036064 · Cited by 19
Implementing circulating tumor DNA analysis in a clinical laboratory: A user manual
Koessler, T., Addeo, A., & Nouspikel, T. (2019) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.12.004 · Cited by 17
Clinical Validation of a Cell-Free DNA Gene Panel
Cheng, J., Cao, Y., Macleay, A., Lennerz, J. K., Baig, A., Frazier, R. P., Lee, J., Hu, K., Pacula, M., Meneses, E., et al. (2019) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2019.02.008 · Cited by 18
From the bench to the bed: individualizing treatment in non-small-cell lung cancer
Santarpía, M., Altavilla, G., Salazar, F., Tarón, M., & Rosell, R. (2006) · Clinical & Translational Oncology · doi:10.1007/s12094-006-0161-2 · Cited by 17
Zhao, J., Li, J., & Zhang, R. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188926 · Cited by 19
Impact of cfDNA Reference Materials on Clinical Performance of Liquid Biopsy NGS Assays
Hallermayr, A., Keßler, T., Fujera, M., Liesfeld, B., Bernstein, S., von Ameln, S., Schanze, D., Steinke‐Lange, V., Pickl, J. M. A., Neuhann, T., et al. (2023) · Cancers · doi:10.3390/cancers15205024 · Cited by 17
Relationship between exosomes and cancer: formation, diagnosis, and treatment
Huang, C., Li, J., Xie, Z., Hu, X., & Huang, Y. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.95763 · Cited by 23
Tiemann‐Boege, I., Curtis, C. N., Shinde, D. N., Goodman, D. B., Tavaré, S., & Arnheim, N. (2009) · Analytical Chemistry · doi:10.1021/ac900633y · Cited by 16
Kasahara, N., Kenmotsu, H., Serizawa, M., Umehara, R., Ono, A., Hisamatsu, Y., Wakuda, K., Omori, S., Nakashima, K., Taira, T., et al. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.02.001 · Cited by 17
Circulating tumour DNA as a cancer biomarker
Duffy, M. J. (2018) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563218798401 · Cited by 18
Application of cell-free DNA for genomic tumor profiling: a feasibility study
Ahlborn, L. B., Rohrberg, K. S., Gabrielaitė, M., Tuxen, I. V., Yde, C. W., Spanggaard, I., Santoni‐Rugiu, E., Nielsen, F. C., Lassen, U., Mau‐Sørensen, M., et al. (2019) · Oncotarget · doi:10.18632/oncotarget.26642 · Cited by 19
Zhao, Y., He, J. Y., Cui, J., Meng, Z.-Q., Zou, Y. L., Guo, X. S., Chen, X., Wang, X., Yan, L.-T., Han, W., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-07172-x · Cited by 16
DNA Methylation Change Profiling of Colorectal Disease: Screening towards Clinical Use
Yi, J. M. (2021) · Life · doi:10.3390/life11050412 · Cited by 16
Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma
Zhang, Y., Liu, Z., Ji, K., Li, X., Wang, C., Ren, Z., Liu, Y., Chen, X., Han, X., Meng, L., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.736330 · Cited by 18
Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer
Sassu, C. M., Palaia, I., Boccia, S. M., Caruso, G., Perniola, G., Tomao, F., Donato, V. D., Musella, A., & Muzii, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413650 · Cited by 16
Wang, B., Pei, J., Wang, S., Cheng, K. D., Yu, J., & Liu, J. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103771 · Cited by 20
PCR digitale en micro-compartiments: I. Détection sensible de séquences d’acides nucléiques rares
Perez‐Toralla, K., Pekin, D., Bartolo, J.-F., Garlan, F., Nizard, P., Laurent‐Puig, P., Baret, J., & Taly, V. (2015) · médecine/sciences · doi:10.1051/medsci/20153101017 · Cited by 21
Clinical applications of liquid biopsies in gastrointestinal oncology
Zhu, J., & Strickler, J. H. (2016) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2016.08.08 · Cited by 16
Lung and Abdominal Biopsies in the Age of Precision Medicine
Dalag, L., Fergus, J., & Zangan, S. M. (2019) · Seminars in Interventional Radiology · doi:10.1055/s-0039-1693121 · Cited by 16
Husain, N., Verma, T., Kumari, S., Mishra, S., Rastogi, M., Tiwari, V., Agarwal, G., & Anand, N. (2020) · Indian Journal of Pathology and Microbiology · doi:10.4103/ijpm.ijpm_28_20 · Cited by 16
Eide, N. A., Faye, R. S., Høifødt, H. K., Sandstad, B., Qvale, G. A., Faber, R. T., Jebsen, P., Kvalheim, G., & Fodstad, Ø. (2015) · Acta Ophthalmologica · doi:10.1111/aos.12462 · Cited by 16
Hallermayr, A., Steinke‐Lange, V., Vogelsang, H., Rentsch, M., de Wit, M., Haberl, C., Holinski‐Feder, E., & Pickl, J. M. A. (2022) · Cancers · doi:10.3390/cancers14030851 · Cited by 15
Promising and Minimally Invasive Biomarkers: Targeting Melanoma
Spiliopoulou, P., Lopes, C. D. H., & Spreafico, A. (2023) · Cells · doi:10.3390/cells13010019 · Cited by 16
Lippert, J., Smith, G., Appenzeller, S., Landwehr, L., Prete, A., Steinhauer, S., Asia, M. F., Urlaub, H., Elhassan, Y., Kircher, S., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae022 · Cited by 17
Circulating Tumor DNA: A Step into the Future of Cancer Management
Marques, J. F., Reis, J. P., Fernandes, G., Hespanhol, V. P., Machado, J. C., & Costa, J. L. (2019) · Acta Cytologica · doi:10.1159/000492917 · Cited by 16
Biomarkers for Liquid Biopsies of Pituitary Neuroendocrine Tumors
Gossing, W., Frohme, M., & Radke, L. (2020) · Biomedicines · doi:10.3390/biomedicines8060148 · Cited by 16
Cell-Free DNA for the Management of Classical Hodgkin Lymphoma
Camus, V., & Jardin, F. (2021) · Pharmaceuticals · doi:10.3390/ph14030207 · Cited by 18
Metadata
- Authors
- Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-10-28
- Volume
- 102
- Issue
- 45
- Pages
- 16368-16373
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1283450
- OpenAlex
- W2015438948
- Cited by
- 1,188
- References
- 39
- Citations by year
- 2026: 17 · 2025: 34 · 2024: 44 · 2023: 75 · 2022: 91 · 2021: 76 · 2020: 88 · 2019: 111 · 2018: 97 · 2017: 93 · 2016: 90 · 2015: 66 · 2014: 61 · 2013: 46 · 2012: 44
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA62924, CA43460, CA57345)
- National Cancer Institute (CA 57345, CA43460, R37CA043460, R01CA057345, P50CA062924, R37CA057345, CA 62924)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Keywords
- circulating tumor DNA, colorectal cancer, APC mutation, liquid biopsy, early cancer detection
- MeSH terms
- Adult, Aged, Aged, 80 and over, DNA, Neoplasm, Female, Humans, Male, Middle Aged, Mutation, Sensitivity and Specificity, Colorectal Neoplasms, Genes, APC
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.